Metoprolol vs. carvedilol or carvedilol plus N-acetyl cysteine on post-operative atrial fibrillation: A randomized, double-blind, placebo-controlled study

European Heart Journal

Volumn 34, Issue 8, 2013, Pages 597-604

  Ozaydin, Mehmet ^a   Icli, Atilla ^a   Yucel, Habil ^a   Akcay, Selahaddin ^a   Peker, Oktay ^a   Erdogan, Dogan ^a   Varol, Ercan ^a   Dogan, Abdullah ^a   Okutan, Huseyin ^a  

^a SULEYMAN DEMIREL UNIVERSITY   (Turkey)

Author keywords

Atrial fibrillation; Carvedilol; N acetyl cysteine

Indexed keywords

ACETYLCYSTEINE; AMIODARONE; CARVEDILOL; METOPROLOL; PLACEBO;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVERSION; CORONARY ARTERY BYPASS GRAFT; ELECTIVE SURGERY; FEMALE; HEART ATRIUM FIBRILLATION; HEART RATE; HEART SURGERY; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; POST OPERATIVE ATRIAL FIBRILLATION; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL;

ACETYLCYSTEINE; ADULT; AGED; ANALYSIS OF VARIANCE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARBAZOLES; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; HUMANS; LENGTH OF STAY; METOPROLOL; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROPANOLAMINES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84874463730     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs423     Document Type: Article

References (30)

1. Elahi MM, Flatman S, Matata BM. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon. Eur J Cardiovasc Prev Rehabil 2008;15:735-741.
2. Baker WL, Anglade MW, Baker EL, White CM, Kluger J, Coleman CI. Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a metaana-lysis. Eur J Cardiothorac Surg 2009;35:521-527.
3. Gu WJ, Wu ZJ, Wang PF, Htet Aung LH, Yin RX. N-acetylcysteine supplementation for the prevention of atrial fibrillation after cardiac surgery: a meta-analysis of eight randomized controlled trials. BMC Cardiovasc Dis 2012;12:10.
4. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, Bauer JA, Tchou PJ, Niebauer MJ, Natale A, Van Wagoner DR. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001;104:2886-2891.
5. Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, Bauer JA. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001;104:174-180.
6. Kim YH, Lim DS, Lee JH, Shim WJ, Ro YM, Park GH, Becker KG, Cho-Chung YS, Kim MK. Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp Mol Med 2003;35:336-349.
7. Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007; 115:135-143.
8. Carnes CA, Chung MK, Nakayama T, Nakayama H, Baliga RS, Piao S, Kanderian A, Pavia S, Hamlin RL, McCarthy PM, Bauer JA, Van Wagoner DR. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 2001;89: e32-e38.
9. Acikel S, Bozbas H, Gultekin B, Aydinalp A, Saritas B, Bal U, Yildirir A, Muderrisoglu H, Sezgin A, Ozin B. Comparison of the efficacy of metoprolol and carvedilol for preventing atrial fibrillation after coronary bypass surgery. Int J Cardiol 2008;126:108-113.
10. Haghjoo M, Saravi M, Hashemi MJ, Hosseini S, Givtaj N, Ghafarinejad MH, Khamoushi AJ, Emkanjoo Z, Fazelifar AF, Alizadeh A, Sadr-Ameli MA. Optimal beta-blocker for prevention of atrial fibrillation after on-pump coronary artery bypass graft surgery: carvedilol versus metoprolol. Heart Rhythm 2007;4: 1170-1174.
11. Merritt JC, Niebauer M, Tarakji K, Hammer D, Mills RM. Comparison of effectiveness of carvedilol versus metoprolol or atenolol for atrial fibrillation appearing after coronary artery bypass grafting or cardiac valve operation. Am J Cardiol 2003;92:735-736.
12. Ozaydin M, Peker O, Erdogan D, Kapan S, Turker Y, Varol E, Ozguner F, Dogan A, Ibrisim E. N-Acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study. Eur Heart J 2008;29: 625-631.
13. McMurray J, Køber L, Robertson M, Dargie H, Colucci W, Lopez-Sendon J, Remme W, Sharpe DN, Ford I. Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. J Am Coll Cardiol 2005;45: 525-530.
14. Kamei M, Morita S, Hayashi Y. Carvedilol versus metoprolol for the prevention of atrial fibrillation after off-pump coronary bypass surgery: rationale and design of the Carvedilol or Metoprolol Post-Revascularization Atrial Fibrillation Controlled Trial (COMPACT). Cardiovasc Drugs Ther 2006;20:219-227.
15. Neuman RB, Bloom HL, Shukrullah I, Darrow LA, Kleinbaum D, Jones DP, Dudley SC Jr. Oxidative stress markers are associated with persistent atrial fibrillation. Clin Chem 2007;53:1652-1657.
16. Goettea A, Lendeckel U. Nonchannel drug targets in atrial fibrillation. Pharmacol Ther 2004;102:17-36.
17. Patti G, Chello M, Candura D, Pasceri V, D'Ambrosio A, Covino E, Di Sciascio G. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 2006;114:1455-1461.
18. Dhalla NS, Temsah RM, Netticadan D. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000;18:655-673.
19. Sucu N, Cinel I, Unlu A, Aytacoglu B, Tamer L, Kocak Z, Karaca K, Gul A, Dikmengil M, Atik U, Oral U. N-Acetylcysteine for preventing pump induced oxi-doinflammatory response during cardiopulmonary bypass. Surg Today 2004;34: 237-242.
20. Koramaz I, Pulathan Z, Usta S, Karahan SC, Alver A, Yaris E, Kalyoncu NI, Ozcan F. Cardioprotective effect of cold blood cardioplegia enriched with N-acetylcysteine during coronary artery bypass grafting. Ann Thorac Surg 2006; 81:613-618.
21. Vento AE, Nemlander A, Aittomaki J, Salo J, Karhunen J, Rämö OJ. N-Acetylcysteine as an additive to crystalloid cardioplegia increased oxidative stress capacity in CABG patients. Scand Cardiovasc J 2003;37:349-355.
22. Orhan G, Yapici N, Yuksel M, Sargin M, Senay S, Yalçin AS, Aykac Z, Aka SA. Effects of N-acetylcysteine on myocardial ischemia-reperfusion injury in bypass surgery. Heart Vessels 2006;21:42-47.
23. Sochman J, Kolc J, Vrana M, Fabian J. Cardioprotective effects of N-acetylcysteine: the reduction in the extent of infarction and occurrence of reperfusion arrhythmias in the dog. Int J Cardiol 1990;28:191-196.
24. El-Hamamsy I, Stevens LM, Carrier M, Pellerin M, Bouchard D, Demers P, Cartier R, Page P, Perrault LP. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 2007;133:7-12.
25. Wang G, Bainbridge D, Martin J, Cheng D. N-Acetylcysteine in cardiac surgery: do the benefits outweigh the risks? A meta-analytic reappraisal. J Cardiothorac Vasc Anesth 2011;25:268-275.
26. El-Sheriff N, Turitto G. Electrophysiologic effects of carvedilol: is carvedilol an antiaahytmic agent? Pacing Clin Electrophysiol 2005;28:985-990.
27. McTavish D, Campoli-Richards D, Sorkin EM. Carvedilol. A review of its pharma-codynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1993; 45:232-258.
28. Li X, Li S, Xu Z, Lou MF, Anding P, Liu D, Roy SK, Rozanski GJ. Redox control of K channel modelling in rat ventricle. J Mol Cell Cardiol 2006;40: 339-349.
29. Carnes CA, Janssen PM, Ruehr ML, Nakayama H, Nakayama T, Haase H, Bauer JA, Chung MK, Fearon IM, Gillinov AM, Hamlin RL, Van Wagoner DR. Atrial glutathi-one content, calcium current, and contractility. J Biol Chem 2007;282: 28063-28073.
30. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH; ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012;366:120-129.